Assistant Professor in Hematology and Medical Oncology at Mayo Clinic, MN, USA. Tweets are my own.
Joined April 2019
- Tweets508
- Following345
- Followers802
- Likes1.5K
Jithma Abeykoon, M.D. retweeted
Our hematologist Dr. Jithma Abeykoon cares for people with lymphoma and histiocytic cancers and conducts research focused on understanding and delineating disease biology and discovering new treatment strategies for individuals with these cancers: mayo.edu/research/faculty/ab….
Meet the 2026 ECOG-ACRIN Young Investigator Symposium presenters, who will share innovative #CancerResearch tomorrow in Philadelphia: bit.ly/YIS26
@JithmaA @FahminB_MDPhD @FedGhali @Jani_Chinmay @CathyHandy @ShachiMittal2 @fangdisun @VarshaS53228024 & Allison Matous
Jithma Abeykoon, M.D. retweeted
Congratulations to the early-career researchers selected to present at our annual Young Investigator Symposium! Great session this morning! Cc: @JithmaA @FahminB_MDPhD @FedGhali @Jani_Chinmay @CathyHandy @ShachiMittal2 @fangdisun @VarshaS53228024 #eaonc #CancerResearch
Jithma Abeykoon, M.D. retweeted
Meet the 2026 ECOG-ACRIN Young Investigator Symposium presenters, who will share innovative #CancerResearch tomorrow in Philadelphia: bit.ly/YIS26
@JithmaA @FahminB_MDPhD @FedGhali @Jani_Chinmay @CathyHandy @ShachiMittal2 @fangdisun @VarshaS53228024 & Allison Matous
Our basic research work from the @Witzig/Abeykoon lab got selected to be presented at the Young Investigator Symposium, ECOG/ACRIN 2026. Thank you for this recognition @eaonc @MayoCancerCare @MayoHemeOnc
Jithma Abeykoon, M.D. retweeted
I had the opportunity to get to know Dr. Kyle while working together on an article and came to appreciate his intellect and humanity. His legacy will endure for generations. May his memory be a blessing.
@DavidSteensma
@VincentRK
@MayoClinicCV
We join the oncology community in mourning the passing of Dr. Robert A. Kyle, whose transformative hematology research was celebrated with our Karnofsky Award in 2007.
Learn more about Dr. Kyle's career: bit.ly/4h2E4AR
Jithma Abeykoon, M.D. retweeted
Yes
Jithma Abeykoon, M.D. retweeted
NGS Profiling Is Essential for All Rosai-Dorfman Disease Tumors - Jithma Abeykoon
@JithmaA
oncodaily.com/new-paper-aler…
NGS needs to be done on all RDD tumors. Important clinically and theraputically. See our publication.
Mutational profiling links biologically relevant variants to multisystemic Rosai-Dorfman disease ashpublications.org/bloodadv…
Deeply saddened by the passing of Dr. Robert Kyle, a hematology giant and legendary Mayo Clinic mentor. His research defined plasma cell disorders, but his humility and patient dedication set the standard. A monumental loss to medicine, his legacy remains our guiding light. RIP.
Profound sorry that my mentor, friend, and colleague, the legend Bob Kyle passed away. His contributions to patients, medicine, myeloma, @IMFmyeloma @MayoClinic myeloma group, and the institution are monumental. A role model who will be remembered for his integrity and commitment to patients. I owe my career to him. He leaves behind a legacy of experts at Mayo Clinic as well as world over who were influenced greatly by him.
See thread for links to a video an article on him that I wrote for @MayoProceedings
Post your memories below.
NIH/NCI K08 funded. 3rd percentile score. Huge thank and gratitude to my mentors Tom Witzig, Z. Lou, @MrinalPatnaik, Alan D'Andrea, Geoff Shapiro, Matt Maurer, A Novak and others. Thank You @MayoCancerCare @NIH @MayoLymphoma @WitzigLab. Now here we go! :)
Jithma Abeykoon, M.D. retweeted
New Insights on MMEJ Disruption in Ewing Sarcoma - Jithma Abeykoon (@JithmaA)
oncodaily.com/science/jithma…
Hot off the press. See our latest work on the association of MMEJ and oncogene-driven cancer biology.
Disruption of microhomology-mediated end joining in Ewing sarcoma: Molecular Cell cell.com/molecular-cell/full…
Jithma Abeykoon, M.D. retweeted
Registration is now open for the 2026 Patient & Family Gathering in Birmingham, Alabama, April 29–30. Join patients, families, and caregivers to connect, learn from experts, and explore the latest research. Reserve your hotel by April 6.
erdheim-chester.org/reminder…
Check it out " HPV16 E6 oncoprotein promotes microhomology-mediated viral integration by increasing PolΘ protein expression | PNAS pnas.org/doi/10.1073/pnas.25…
@pnas
MMEJ is very relevant in the pathobiology of oncogene driven malignancy. More to come!
Jithma Abeykoon, M.D. retweeted
#letstalkhistiocytosis
Join us live on March 18!
Registration is open to all
us02web.zoom.us/webinar/regi…
I couldn’t be more thrilled & honored to share the stage with Dr. Jennifer Picarsic @jpcrsc to discuss the many faces of Histiocytosis diagnostics in clinical practice
Don’t miss the upcoming webinar on March 18!
The many faces of Histiocytosis: Decoding Diagnosis, Dodging Pitfalls, and Mastering the Mimics.
Register here:
us02web.zoom.us/webinar/regi…
More details in the thread below 👇🏼
Jithma Abeykoon, M.D. retweeted
Finally out in press!
Multi-institutional cohort of patients with Waldenström macroglobulinemia uniformly treated with bendamustine-rituximab (BR).
⏱ Median follow-up: 5.9 years
🔹 5-year PFS: 65%
🔹 5-year OS: 87%
Key highlights:
🌟 CXCR4 mutations identify a subgroup with markedly inferior PFS despite BR
🌟 POD24 is independently associated with inferior overall survival
Huge thanks to the amazing collaborators across US and Europe.
@JithmaA @MyelomaDrKapoor @VincentRK @Myeloma_mSMART @thanosdimop @ShirleyDSa1 @jonaspaludo
ashpublications.org/bloodadv…
Jithma Abeykoon, M.D. retweeted
2/
#3540: High-resolution WES across WM disease states reveals TP53 and MAP3K14 alterations accumulating at relapse. Distinct CNA patterns, including BCL6 gains and strong signal of non-canonical MAPK activity in relapsed WM, define treatment-exposed and high-risk biology.
@JithmaA
Jithma Abeykoon, M.D. retweeted
Mayo Clinic in Rochester has been named the No. 1 smart hospital in the world by Newsweek's "World's Best Smart Hospitals 2026" and earned more No. 1 specialty rankings than any other hospital in the "World's Best Specialized Hospitals 2026" list.
More: newsnetwork.mayoclinic.org/d…
Jithma Abeykoon, M.D. retweeted
A comprehensive review article on the risk stratification of all plasma cell disorders by @VincentRK
@ZanwarSaurabh
Myeloma, MGUS, SMM, Amyloid, WM — all here.
Open Access. nature.com/articles/s41375-0…
Very important meeting for patients with histiocytic cancers. Consider attending histiocytesociety.org/HS-202…